Onde · waves · where

Owning the middle. We move discovery to solutions.

Onde puts the right type of capital at each risk stage of women's health science, so better treatments and diagnostics reach women faster. Grants fund the riskiest early work on endometriosis, adenomyosis and menopause. Our venture arm deploys capital fast once a company can carry it.

The problem

Good research on conditions that mainly affect women already exists. Much of it stops at a published paper.

Turning a finding into a test or a treatment takes a different kind of money. It pays for validation studies, prototypes and early clinical work. In women's health that stage rarely gets funded. So promising work sits still, and women wait.

Why Onde exists

Onde exists so women can thrive. We want resources to reach women's health faster, so women have more options for diagnosis and treatment, sooner.

Two arms, one mission

Grant foundation

Gives substantial grants through universities, hospitals and research institutes. The grants move work closer to the clinic and help teams get ready to build a company.

Venture arm

Backs companies that grow out of our grants, and companies that come to us directly, once they can carry investment.

Both arms serve the same mission. If a company we help create succeeds, the returns go back to the mission, never to donors.

Focus

What we focus on

01

Endometriosis

A chronic inflammatory condition. Women can wait years for a diagnosis. The WHO puts the delay at 4 to 12 years.

02

Adenomyosis

Often missed, and studied far less than the burden it puts on daily life.

03

Menopause

Every woman who lives long enough goes through it. We want a better understanding of symptoms and long term health, and better ways to treat them.

Source: WHO, Endometriosis fact sheet, 24 March 2023.

See how Onde is planned to work →